MedPath
HSA Approval

ZADITEN SYRUP 1 mg/5 ml (sugar-free)

SIN07573P

ZADITEN SYRUP 1 mg/5 ml (sugar-free)

ZADITEN SYRUP 1 mg/5 ml (sugar-free)

December 15, 1993

NOVARTIS (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AX17

ketotifen

Manufacturer Information

NOVARTIS (SINGAPORE) PTE LTD

DELPHARM HUNINGUE SAS

Active Ingredients

KETOTIFEN HYDROGEN FUMARATE EQV KETOTIFEN

1 mg/5 ml

Ketotifen

Documents

Package Inserts

Zaditen_PI.pdf

Approved: July 1, 2016

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.